BioCanvas
표적 · PKG

PKG 항체

1최다 인용
25인용된 항체
12벤더
Antibody Registry데이터 출처 · RRID CC0

논문 인용순 항체

Antibody Registry 인용수 기준 · 25종
1
MBL International#JM-3452-100 RRID:AB_593072 polyclonal
1
cited by
2
Santa Cruz Biotechnology#sc-10335 RRID:AB_673836 polyclonal
1
cited by
3
Enzo Life Sciences#KAP-PK005D RRID:AB_2170659 polyclonal
1
cited by
4
Proteintech#21646-1-AP RRID:AB_2878897 polyclonal
1
cited by
5
GeneTex#GTX12257 RRID:AB_369429 polyclonal
0
cited by
6
GeneTex#GTX12258 RRID:AB_369430 polyclonal
0
cited by
7
Novus#NB 100-1989 RRID:AB_535806 polyclonal
0
cited by
8
Santa Cruz Biotechnology#sc-10341 RRID:AB_638433 polyclonal
0
cited by
9
Acris Antibodies#AP00187PU-N RRID:AB_1006403 unknown
0
cited by
10
GenWay Biotech Inc.#18-272-195676-0.05 mg RRID:AB_1027040 polyclonal
0
cited by
11
GenWay Biotech Inc.#18-272-195677-0.05 ml RRID:AB_1027041 polyclonal
0
cited by
12
Atlas Antibodies#HPA007699 RRID:AB_1079677 polyclonal
0
cited by
13
Enzo Life Sciences#KAP-PK005F RRID:AB_1083781 polyclonal
0
cited by
14
Enzo Life Sciences#KAP-PK005D RRID:AB_1083783 polyclonal
0
cited by
15
Abnova#H00005592-B01 RRID:AB_1114990 polyclonal
0
cited by
16
Abnova#PAB3192 RRID:AB_1579169 polyclonal
0
cited by
17
Abnova#PAB8922 RRID:AB_1711777 polyclonal
0
cited by
18
Enzo Life Sciences#KAP-PK002D RRID:AB_1831851 polyclonal
0
cited by
19
Enzo Life Sciences#KAP-PK002F RRID:AB_1831852 polyclonal
0
cited by
20
Enzo Life Sciences#ADI-KAP-PK005-D RRID:AB_2039483 unknown
0
cited by
21
Enzo Life Sciences#ADI-KAP-PK002-D RRID:AB_2039484 unknown
0
cited by
22
abcepta#AP8000A RRID:AB_2170652 polyclonal
0
cited by
23
Millipore#PK1018 RRID:AB_2170657 polyclonal
0
cited by
24
Enzo Life Sciences#KAP-PK002D RRID:AB_2170661 polyclonal
0
cited by
25
Santa Cruz Biotechnology#sc-25429 RRID:AB_2170663 polyclonal
0
cited by
이 표적 항체를 국내 공급가·납기로 확인하시겠어요? 국내 구매·견적 문의 →

PKG

이 표적에 논문에서 가장 많이 인용된 항체 순으로 정리했습니다. 각 행에서 국내 견적을 요청할 수 있습니다.

Data: Antibody Registry (SciCrunch) — RRID under CC-0; product metadata per respective source. Citation counts: Antibody Registry.